Specific immunotherapy using a recombinant vaccinia virus expressing human carcinoembryonic antigen.
Kantor
J
J
Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland 20892.
Abrams
S
S
Irvine
K
K
Snoy
P
P
Kaufman
H
H
Schlom
J
J
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy*; D000818:Animals; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D003110:Colonic Neoplasms / Q000276:immunology / Q000628:therapy*; D051379:Mice; D009368:Neoplasm Transplantation; D014614:Vaccines, Synthetic; D014616:Vaccinia virus; D014765:Viral Vaccines / Q000276:immunology
D002272:Carcinoembryonic Antigen; D014614:Vaccines, Synthetic; D014765:Viral Vaccines